Adhavok Mukherjee
Chief Financial Officer
Replay available
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q3 2025 earnings conference call, held 2025-11-04. Replay captured from the company's public earnings webcast.

Chief Financial Officer
Chief Business Officer
President, Endocrinology Division
Chief Executive Officer
Chief Development Officer
Analyst, Canaccord Genuity
Analyst, Piper Sandler
Analyst, Truist Securities
Watch the replay and follow the connected company analysis, news, and investor updates for Corcept Therapeutics Incorporated.
WEBVTT 00:00:00.031 -- 00:00:05.238 2025 Earnings Conference Call. At this time, all participants 00:00:05.238 -- 00:00:10.505 are in a listen-only mode. After the speaker presentation, there will be a question 00:00:10.505 -- 00:00:15.712 and answer session. To ask a question during the session, you will need to press star 00:00:15.712 -- 00:00:22.000 1-1 on your telephone. To remove yourself from the queue, you may press star 1-1 again. 00:00:22.000 -- 00:00:26.165 I would now like to hand the call over to Adhavok Mukherjee, CFO. 00:00:26.165 -- 00:00:28.906 Please go ahead. 00:00:29.109 -- 00:00:32.085 Hello, everyone. Good afternoon and thank you for joining us. 00:00:32.085 -- 00:00:36.110 Today we issued a press release announcing our financial results for the third quarter 00:00:36.110 -- 00:00:40.214 and providing a corporate update. A copy is available at coursehub.com. 00:00:40.214 -- 00:00:44.058 Our complete financial results will be available when we file our Form 10-Q with the 00:00:44.058 -- 00:00:48.924 SEC. Today's call is being recorded. A replay will be available at the Investor's Past 00:00:48.924 -- 00:00:53.929 Events tab of our website. We will also post a presentation regarding our oncology development 00:00:53.929 -- 00:00:58.895 programs in the same section. Statements during this call, other than statements of historical 00:00:58.895 -- 00:01:03.588 fact, Our forward-looking statements, based on our plans and expectations, are subject 00:01:03.588 -- 00:01:07.933 to risks and uncertainties which might cause actual results to be materially different 00:01:07.933 -- 00:01:10.917 from those such statements express or imply. 00:01:10.917 -- 00:01:15.043 The risks and uncertainties that may affect our forward-looking statements are described 00:...